Joseph Palumbo
Hoofd Techniek/Wetenschap/O&O bij BIOVIE INC.
Vermogen: 3 633 $ op 30-04-2024
Actieve functies van Joseph Palumbo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOVIE INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 | - |
HYDREIGHT TECHNOLOGIES INC. | Directeur/Bestuurslid | 25-11-2022 | - |
Loopbaan van Joseph Palumbo
Eerdere bekende functies van Joseph Palumbo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ZYNERBA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2019 | 01-10-2021 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - | - |
Opleiding van Joseph Palumbo
University of Pennsylvania Graduate School of Education | Undergraduate Degree |
George Washington University School of Medicine & Health | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Japan | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Retail Trade | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
JOHNSON & JOHNSON | Health Technology |
ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
BIOVIE INC. | Health Technology |
HYDREIGHT TECHNOLOGIES INC. | Retail Trade |
Bedrijven in privébezit | 1 |
---|---|
Mitsubishi Tanabe Pharma Corp.
Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
- Beurs
- Insiders
- Joseph Palumbo
- Ervaring